Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison represented Sun Country Airlines, Inc. and Apollo Global Management, Inc., while Davis Polk & Wardwell acted as counsel for the...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters involved in the offering. Deutsche Bank AG, acting through its New York branch, announced the SEC-registered offering of $1.5 billion aggregate...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Morgan Stanley Alternative Investment Partners on the operation. Morgan Stanley Investment Management (MSIM), an affiliate of Morgan Stanley Alternative Investment Partners (AIP), announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk & Wardwell advised the representatives of the several underwriters. Prometheus Biosciences,...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Shoals Technologies Group, while Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. Shoals Technologies Group,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. FREYR Battery announced the $264.5 million debut registered equity offering of 23,000,000 of its ordinary shares, which includes the full...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Honigman advised Prime Medicine on the deal, while Davis Polk advised the joint book-running managers. Prime Medicine, Inc., a biotechnology company committed to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the underwriters in the offering. Gamida Cell Ltd. announced the $20 million SEC-registered follow-on offering of 12,905,000 ordinary shares. The ordinary shares...
You must be a Standard 1 Year member to access this content.
Paul, Weiss advised Alignment Healthcare, while Davis Polk advised the underwriter, J.P. Morgan Securities LLC, in the offering. Alignment Healthcare executed its SEC-registered secondary offering of 9,000,000...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Oak Street Health, Inc. announced the $180.3 million secondary offering of 7,000,000 million shares of common stock...
You must be a Standard 1 Year member to access this content.
